Search

Your search keyword '"Murai, H."' showing total 1,100 results

Search Constraints

Start Over You searched for: Author "Murai, H." Remove constraint Author: "Murai, H."
1,100 results on '"Murai, H."'

Search Results

1. P277 Long-term safety, tolerability, and efficacy of Efgartigimod in patients with Generalized Myasthenia Gravis: concluding analyses from the ADAPT+ study

2. PB1334 Safety Profile of Efgartigimod from Clinical Trials in Participants with Immunoglobulin G-Mediated Autoimmune Diseases

6. Advances and ongoing research in the treatment of autoimmune neuromuscular junction disorders

8. New advances to prepare GYSELA-X code for exascale global gyrokinetic plasma turbulence simulations: porting on GPU and ARM architectures

14. ‘Minimal symptom expression’ in patients with acetylcholine receptor antibody-positive refractory generalized myasthenia gravis treated with eculizumab

15. Consistent improvement with eculizumab across muscle groups in myasthenia gravis

16. Safety, efficacy, and tolerability of efgartigimod in patients with generalised myasthenia gravis (ADAPT) : a multicentre, randomised, placebo-controlled, phase 3 trial

21. Management bundles for candidaemia: the impact of compliance on clinical outcomes

22. International Consensus Guidance for Management of Myasthenia Gravis 2020 Update

23. Eculizumab in refractory generalized myasthenia gravis previously treated with rituximab:subgroup analysis of REGAIN and its extension study

24. International Consensus Guidance for Management of Myasthenia Gravis: 2020 Update

25. Eculizumab Improves Fatigue in Refractory Generalized Myasthenia Gravis

27. ‘Minimal symptom expression’ in patients with acetylcholine receptor antibody-positive refractory generalized myasthenia gravis treated with eculizumab

42. Novel index of arterial reflected waves, Arterial Velocity pulse Index, relates to muscle sympathetic nerve activity independent of Arterial Pressure volume Index in patients with hypertension

48. Long-term safety and efficacy of eculizumab in generalized myasthenia gravis

49. Correction to: Eculizumab improves fatigue in refractory generalized myasthenia gravis (Quality of Life Research, (2019), 28, 8, (2247-2254), 10.1007/s11136-019-02148-2)

Catalog

Books, media, physical & digital resources